Pharmacy Medical News about cost-effectiveness

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial
Cost Effectiveness and Resource Allocation, 04/29/09

Smit F et al. - The median incremental cost-effectiveness ratio is E6,198 per PD-free survival gained, which has a likelihood of 75.2% of being more acceptable from a cost-effectiveness point of view than care-as-usual when a willingness-to-pay ceiling is assumed of E10,000 per PD-free survival. The most significant cost driver was therapists' time. A sensitivity analysis indicated that cost-effectiveness improves when the number of therapist hours is reduced.

<< Previous
Looking toward basic science for potential drug discovery targets...

Next >>
Economy Hitting Hospitals Hard